메뉴 건너뛰기
Annals of Hematology
Volumn 88, Issue 3, 2009, Pages 281-282
Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia
Author keywords

[No Author keywords available]
Indexed keywords

BCR ABL PROTEIN; IMATINIB; IMMUNOGLOBULIN A; IMMUNOGLOBULIN KAPPA CHAIN; INTERFERON; MELPHALAN; PREDNISOLONE;
EID: 59049083736     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0597-2     Document Type: Letter
Times cited : (15)
References (5)
  • 1
    • 0033113498 scopus 로고    scopus 로고
    • Multiple myeloma preceding the development of chronic myelogenous leukemia
    • Nitta M, Tsuboi K, Yamasita S, Kato M, Hayami Y, Harada S et al (1999) Multiple myeloma preceding the development of chronic myelogenous leukemia. Int J Hematol 69:170-173
    • (1999) Int J Hematol , vol.69 , pp. 170-173
    • Nitta, M.1    Tsuboi, K.2    Yamasita, S.3    Kato, M.4    Hayami, Y.5    Harada, S.6
  • 2
    • 0037434853 scopus 로고    scopus 로고
    • Imatinib mesylate - The new gold standard for treatment of chronic myeloid leukemia
    • doi: 10.1056/NEJMe030009
    • Peggs K, Mackinnon S (2003) Imatinib mesylate - the new gold standard for treatment of chronic myeloid leukemia. N Engl J Med 348:1048-1050 doi: 10.1056/NEJMe030009
    • (2003) N Engl J Med , vol.348 , pp. 1048-1050
    • Peggs, K.1    Mackinnon, S.2
  • 3
    • 22244458317 scopus 로고    scopus 로고
    • Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate
    • doi: 10.1634/theoncologist.10-6-457
    • Garipidou V, Vakalopoulou S, Tziomalos K (2005) Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate. Oncologist 10:457-458 doi: 10.1634/ theoncologist.10-6-457
    • (2005) Oncologist , vol.10 , pp. 457-458
    • Garipidou, V.1    Vakalopoulou, S.2    Tziomalos, K.3
  • 4
    • 0037765477 scopus 로고    scopus 로고
    • Simultaneous occurrence of chronic myeloid leukemia and multiple myeloma: Evaluation by FISH analysis and in vitro expansion of bone marrow cells
    • doi: 10.1038/sj.leu.2402971
    • Schwarzmeier JD, Shehata M, Ackermann J, Hilgarth M, Kaufmann H, Drach J (2003) Simultaneous occurrence of chronic myeloid leukemia and multiple myeloma: Evaluation by FISH analysis and in vitro expansion of bone marrow cells. Leukemia 17:1426-1428 doi: 10.1038/sj.leu.2402971
    • (2003) Leukemia , vol.17 , pp. 1426-1428
    • Schwarzmeier, J.D.1    Shehata, M.2    Ackermann, J.3    Hilgarth, M.4    Kaufmann, H.5    Drach, J.6
  • 5
    • 0348110487 scopus 로고    scopus 로고
    • Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents
    • doi: 10.1046/j.1365-2141.2003.04706.x
    • Pandiella A, Carvajal-Vergara X, Tabera S, Mateo G, Gutierrez N, San Miguel JF (2003) Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents. Br J Haematol 123:858-868 doi: 10.1046/j.1365-2141.2003.04706.x
    • (2003) Br J Haematol , vol.123 , pp. 858-868
    • Pandiella, A.1    Carvajal-Vergara, X.2    Tabera, S.3    Mateo, G.4    Gutierrez, N.5    San Miguel, J.F.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.